WCN26-9171 Effect of Dotinurad versus Febuxostat on the One-Year eGFR Slope in CKD Patients with Hyperuricemia: A Retrospective Cohort Study

Read full text Summarise with VIRAT
Authors: Hikaru Uematsu, Tatsunori Toida, Yuri Tanaka, Nobuhiko Joki
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The renal effects of urate-lowering therapy remain controversial in patients with chronic kidney disease (CKD), particularly for selective urate reabsorption inhibitors (SURI). Dotinurad, a novel SURI, has shown potent uricosuric effects by selectively inhibiting the urate transporter 1 (URAT1). However, comparative data with xanthine oxidase inhibitors (XOI) regarding kidney function trajectories are limited. This study aimed to compare changes in the estimated glomerular filtration rate (eGFR) slope between patients initiating dotinurad and those initiating febuxostat, the most widely used XOI.

Fields of Study & Subjects

Gout Hyperuricemia Uric Acid Chronic Kidney Disease and Diabetes Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104655–104655
Publication date
25 March 2026
Language
EN